老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
EPSILON HEALTHCARE LTD
0.025
0.000
成交量:
- -
成交額:
- -
市值:
972.76萬
市盈率:
185.19
高:
0.025
開:
0.025
低:
0.025
收:
0.025
52周最高:
0.040
52周最低:
0.019
股本:
3.89億
流通股本:
2.70億
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
0.000
每股收益(LYR):
-0.003
淨資產收益率:
50.27%
總資產收益率:
-5.29%
市淨率:
2.51
市盈率(LYR):
-7.35
資料載入中...
總覽
公司
新聞資訊
公告
Epsilon Healthcare攜手Helix與Puro,獨攬全球 cannabinoid 納米乳劑技術製造權
美股速递
·
昨天
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/EPN.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"EPN.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EPN.AU\",,,,,undefined,":{"symbol":"EPN.AU","market":"AU","secType":"STK","nameCN":"EPSILON HEALTHCARE LTD","latestPrice":0.025,"timestamp":1789539120000,"preClose":0.025,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"EPSILON HEALTHCARE LTD","floatShares":269789980,"shares":389104011,"eps":0.000135,"marketStatus":"已收盤","change":0,"latestTime":"09-16 16:12:00 AEST","open":0.025,"high":0.025,"low":0.025,"amount":0,"amplitude":0,"askPrice":0.027,"askSize":140000,"bidPrice":0.026,"bidSize":500000,"shortable":3,"etf":0,"ttmEps":0.000135,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.025,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"EPN.AU","preClose":0.024,"auctionPrice":0.023,"auctionVolume":86257,"auction":3,"marketStatus":"盘后竞价","timestamp":1788329028820}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EPN.AU\",,,,,undefined,":{"symbol":"EPN.AU","floatShares":269789980,"roa":"-5.29%","roe":"50.27%","lyrEps":-0.0034,"shares":389104011,"dividePrice":0,"high":0.025,"amplitude":0,"preClose":0.025,"low":0.025,"week52Low":0.019,"pbRate":"2.51","psRate":"0.72","week52High":0.04,"institutionHeld":0,"latestPrice":0.025,"committee":0.5625,"eps":0.000135,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.000135,"open":0.025,"prevYearClose":0.033,"prevWeekClose":0.027,"prevMonthClose":0.021,"prevQuarterClose":0.022,"fiveDayClose":0.025,"twentyDayClose":0.026,"sixtyDayClose":0.022},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EPN.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EPN.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EPN.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1122009034","title":"Epsilon Healthcare攜手Helix與Puro,獨攬全球 cannabinoid 納米乳劑技術製造權","url":"https://stock-news.laohu8.com/highlight/detail?id=1122009034","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122009034?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 07:30","pubTimestamp":1789428609,"startTime":"0","endTime":"0","summary":"Epsilon Healthcare宣布了一项重大战略举措——与Helix及Puro达成合作,正式成为Helix旗下cannabinoid纳米乳剂技术的全球独家制造合作伙伴。此举标志着Epsilon在健康医疗领域的版图进一步扩张,同时也为cannabinoid技术的商业化应用铺平了道路。此次合作不仅凸显了Epsilon在制造领域的专业实力,更预示着其将在全球市场中扮演更为关键的角色。通过这一独家伙伴关系,Epsilon有望引领cannabinoid纳米乳剂技术的新一轮创新浪潮,为行业树立新的标杆。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPN.AU","BK7096","BK7502"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}